Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial.

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial.

Item
http://www.wikidata.org/entity/Q33442988
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.Hypoxia-Activated Alkylating Agents in BRCA1-Mutant Ovarian Serous Carcinoma.Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapy.Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma.Drug-eluting bead transarterial chemoembolization in the treatment for unresectable soft tissue sarcoma refractory to systemic chemotherapy: a preliminary evaluation of efficacy and safety.Systemic Treatment for Adults with Synovial Sarcoma.Developments in the management of advanced soft-tissue sarcoma - olaratumab in context.Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma
P2860

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial.

Item
http://www.wikidata.org/entity/Q33442988
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Doxorubicin plus evofosfamide ...... bel, randomised phase 3 trial.
@ast
Doxorubicin plus evofosfamide ...... bel, randomised phase 3 trial.
@en
type
label
Doxorubicin plus evofosfamide ...... bel, randomised phase 3 trial.
@ast
Doxorubicin plus evofosfamide ...... bel, randomised phase 3 trial.
@en
prefLabel
Doxorubicin plus evofosfamide ...... bel, randomised phase 3 trial.
@ast
Doxorubicin plus evofosfamide ...... bel, randomised phase 3 trial.
@en
P1433
P1476
P2093
P31
P356
P50
P577
P698
P921
P356
P1433
P1476
Doxorubicin plus evofosfamide ...... bel, randomised phase 3 trial.
@en
P2093
P31
P356
10.1016/S1470-2045(17)30381-9
P50
P577
P698
P921